Table 1 Clinicopathological features of the colorectal cancer patients and control subjects
Characteristic | CRC group | Control group | P value |
|---|---|---|---|
n = 232 (100%) | n = 232 (100%) | ||
Mean Age (years SD) | 60.73 (± 10.25) | 62.45(± 12.39) | 0.103 |
Age (in years) | |||
< 50 | 28 (12.07) | 44 (18.97) | 0.040 |
> 50 | 204 (87.93) | 188 (81.03) | |
Sex | |||
Male | 134 (57.76) | 109 (46.98) | 0.020 |
Female | 98 (42.24) | 123 (53.02) | |
Smoking status | |||
Yes | 79 (34.05) | 37 (15.95) | 0.001 |
No | 153 (65.95) | 195 (84.05) | |
Drinking status | |||
Yes | 65 (28.02) | 29 (12.50) | 0.001 |
No | 167 (71.98) | 203 (87.50) | |
Clinical stage TNM | |||
I | 6 (2.59) | ||
II | 63 (27.16) | ||
III | 87 (37.5) | ||
IV | 76 (32.76) | ||
Tumor location | |||
Colon | 108 (46.55) | ||
Rectum | 124 (53.45) | ||
Site of metastasis | |||
Liver | 29 (38.16) | ||
Lung | 13 (17.11) | ||
Liver and lung | 8 (10.53) | ||
Peritoneum | 3 (3.95) | ||
Lung and peritoneum | 3 (3.95) | ||
Ovary | 1 (1.32) | ||
Brain | 1 (1.32) | ||
No Available | 18 (23.68) | ||
Treatment response | |||
Complete response | 101 (43.53) | ||
Partial response | 68 (29.31) | ||
No response | 63 (27.16) | ||